Ono Richard Dana

CIK 00015959892 companiesTAMPA, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001595989

Recent Transactions

37 trades

Award
Lipocine Inc.$LPCN
Common Stock (Right to Buy)
2025-06-04$3.20/sh+1,764→ 11,526 total
Award
Lipocine Inc.$LPCN
Common Stock (Right to Buy)
2024-06-05$7.05/sh+1,764→ 10,938 total
Award
Lipocine Inc.$LPCN
Common Stock (Right to Buy)
2023-05-10$0.27/sh+30,000→ 166,000 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2023-03-20$0.34/sh+4,000→ 14,125 total
Award
Lipocine Inc.$LPCN
Common Stock (Right to Buy)
2022-06-08$0.92/sh+22,000→ 136,000 total
Award
Lipocine Inc.$LPCN
Common Stock (Right to Buy)
2021-06-09$1.26/sh+22,000→ 22,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock Option
2020-12-22+754,839→ 754,839 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2020-12-16+5,250→ 10,125 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2020-12-16+5,250→ 5,250 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2020-06-10$0.96/sh+22,000→ 22,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock Option
2020-03-20+1,000,000→ 1,000,000 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2019-06-12$1.68/sh+10,000→ 10,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock Option
2019-02-03+657,895→ 657,895 total
Award
Lipocine Inc.$LPCN
Stcck Optoin (right to buy)
2018-06-27$1.33/sh+20,000→ 20,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock Option
2018-03-13+253,000→ 253,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Common Stock Option
2018-03-13+56,000→ 56,000 total
Sale
Lipocine Inc.$LPCN
Common stock
2017-12-29$3.47/sh−875→ 4,875 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2017-12-29−1,750→ 5,250 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2017-12-29+1,750→ 5,750 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2017-03-08+150,000→ 512,400 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2017-03-08+300,000→ 300,000 total
Tax Payment
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2017-03-08$0.34/sh−118,800→ 362,400 total
Tax Payment
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2017-03-08$0.34/sh−59,400→ 453,000 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Restricted Stock Units
2017-03-08−300,000→ 0 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2017-03-08+300,000→ 481,200 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Restricted Stock Units
2017-03-08−300,000→ 0 total
Tax Payment
Inhibitor Therapeutics, Inc.$INTI
Common Stock
2017-03-08$0.34/sh−118,800→ 181,200 total
Exercise/Conversion
Inhibitor Therapeutics, Inc.$INTI
Restricted Stock Units
2017-03-08−150,000→ 0 total
Award
Lipocine Inc.$LPCN
Restricted Stock Unit
2017-01-26+7,000→ 7,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Options to Purchase Common Stock
2016-07-01+150,000→ 150,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Restricted Stock Units
2016-07-01+150,000→ 150,000 total
Award
Lipocine Inc.$LPCN
Common Stock (right to buy)
2016-06-14$8.02/sh+10,000→ 10,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Restricted Stock Units
2015-08-14+300,000→ 300,000 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2015-06-16+20,000→ 30,000 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2014-11-19$5.14/sh+4,000→ 4,000 total
Award
Inhibitor Therapeutics, Inc.$INTI
Restricted Stock Units
2014-07-18+300,000→ 300,000 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2014-01-06+10,000→ 10,000 total

Companies

Recent Filings

Address

324 S. HYDE PARK AVENUE, SUITE 350

TAMPA, FL, 33606

View on SEC.gov